Beren Therapeutics key facts
- Operator of a biotechnology company intended to develop innovative and efficacious therapies to make them accessible to every patient.
- It has raised $138.7M; the latest was Later Stage VC ($8.7M) in Oct 2025.
- Notable investors include Gaingels, Calm Ventures, JIC Venture Growth Investments, Alpha Wave Global, Zain S Hasan Charitable Remainder Trust — 15 tracked in total.
- Status: Privately Held (backing).
Who backs Beren Therapeutics
15+- ·The complete investor list: 15 names
- ·Watch Beren Therapeutics: the Monday email on marks, rounds and moves
Beren Therapeutics funding rounds
No funding rounds for Beren Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Beren Therapeutics investors
15 investors are on record for Beren Therapeutics, including Gaingels, Calm Ventures, JIC Venture Growth Investments and Alpha Wave Global. By type, the record holds 4 venture capital firms, 1 family office and 1 growth equity firm.
About Beren Therapeutics
Operator of a biotechnology company intended to develop innovative and efficacious therapies to make them accessible to every patient. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Thousand Oaks, CA, United States
- Founded
- 2020
- Website
- berentx.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Beren Therapeutics doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.